Lixte Biotechnology Holdings, Inc. (LIXT)
NASDAQ: LIXT · IEX Real-Time Price · USD
2.950
0.00 (0.00%)
May 7, 2024, 10:58 AM EDT - Market open

LIXT Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2006
Cash & Equivalents
4.25.354.825.072.64.271.310.20.030.04
Upgrade
Short-Term Investments
000000000.10.21
Upgrade
Cash & Cash Equivalents
4.25.354.825.072.64.271.310.20.130.26
Upgrade
Cash Growth
-21.48%10.98%-4.84%95.06%-39.18%227.25%553.11%54.53%-49.88%-46.36%
Upgrade
Receivables
000000000.20
Upgrade
Other Current Assets
0.110.210.270.160.070.060.060.230.270.28
Upgrade
Total Current Assets
4.315.565.095.232.674.331.370.430.60.54
Upgrade
Other Long-Term Assets
0000000000
Upgrade
Total Long-Term Assets
0000000000
Upgrade
Total Assets
4.315.565.095.232.674.341.370.430.60.54
Upgrade
Accounts Payable
0.160.230.230.190.140.20.310.160.160.22
Upgrade
Other Current Liabilities
0.160.170.080.030.090.020.060.060.130.06
Upgrade
Total Current Liabilities
0.310.40.30.220.240.210.370.220.290.27
Upgrade
Total Liabilities
0.310.40.30.220.240.210.370.220.290.27
Upgrade
Retained Earnings
-48.48-43.39-37.08-30.35-27.09-24.65-22.52-20.71-18.57-15.72
Upgrade
Shareholders' Equity
3.995.174.795.012.434.1310.210.310.27
Upgrade
Net Cash / Debt
4.25.354.825.072.64.271.310.20.130.26
Upgrade
Net Cash / Debt Growth
-21.48%10.98%-4.84%95.06%-39.18%227.25%553.11%54.53%-49.88%-46.36%
Upgrade
Net Cash Per Share
2.193.383.584.502.334.361.400.250.170.35
Upgrade
Working Capital
3.995.174.795.012.434.1210.210.310.27
Upgrade
Book Value Per Share
2.083.273.564.442.184.211.070.270.400.36
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).